Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cited by (1,000)

Items 101–200 of 1,000

1. Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers
   Hongxian Pang, Wei Xue, Aixin Shi, Min Li, Yang Li, Guoying Cao, Bei Yan, Fan Dong, Wei Lie Xiao, Guorong He et al. · 2016 · Clinical Drug Investigation
2. Design, synthesis and evaluation of novel ferulic acid- O -alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease
   Zhipei Sang, Wanli Pan, Keren Wang, Qinge Ma, Lintao Yu, Yan Gong Yang, Ping Bai, Chaoliang Leng, Qian Xu, Xiaoqing Li et al. · 2017 · European Journal of Medicinal Chemistry
3. Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer’s Inhibitors
   Shoaib Khan, Hayat Ullah, Muhammad Taha, Fazal Rahim, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Rafaqat Hussain, Syed Adnan Alı Shah, Khurshid Ayub et al. · 2023 · Molecules
4. Polypharmacology: The Rise of Multitarget Drugs over Combination Therapies
   Michela Rosini · 2014 · Future Medicinal Chemistry
5. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
   Petra Dunkel, Christina L. L. Chai, Beáta Sperlágh, Paul B. Huleatt, Péter Mátyus · 2012 · Expert Opinion on Investigational Drugs
6. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and β-secretase
   Yiping Zhu, Kun Xiao, Lanping Ma, Bin Xiong, Yan Fu, Haiping Yu, Wei Wang, Xin Wang, Dingyu Hu, Hongli Peng et al. · 2009 · Bioorganic & Medicinal Chemistry
7. Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a “Bio-Oxidizable” Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation
   Ludovic Peauger, Rabah Azzouz, Vincent Gembus, Mihaela-Liliana Ţînţaş, Jana Sopková‐de Oliveira Santos, Pierre Bohn, Cyril A. Papamicaël, Vincent Levacher · 2017 · Journal of Medicinal Chemistry
8. Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy
   Hailin Zheng, Moussa B. H. Youdim, Mati Fridkin · 2010 · ACS Chemical Biology
9. Synthesis, in vitro bio-evaluation, and molecular docking study of thiosemicarbazone-based isatin/bis-Schiff base hybrid analogues as effective cholinesterase inhibitors
   Shoaib Khan, Hayat Ullah, Rafaqat Hussain, Yousaf Khan, Misbah Ullah Khan, Mehmand Khan, Abdul Sattar, Muhammad Saleem Khan · 2023 · Journal of Molecular Structure
10. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases
    Francesco Calzaferri, Cristina Ruiz‐Ruiz, Antonio M. G. de Diego, Ricardo de Pascual, Iago Méndez‐López, María F. Cano‐Abad, Victoria Maneu, Cristóbal de los Rı́os, Luis Gandı́a, Antonio M. G. de Diego · 2020 · Medicinal Research Reviews
11. Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy
    Javad Alizadeh, Simone C. da Silva Rosa, Xiaohui Weng, Joadi Jacobs, Shahrokh Lorzadeh, Amir Ravandi, Rui Miguel Pinheiro Vitorino, Stevan Pecic, Aleksandra Živković, Holger Stark et al. · 2023 · European Journal of Cell Biology
12. Developments with multi-target drugs for Alzheimer’s disease: An overview of the current discovery approaches
    González, Juan F., Alcántara, Andrés R., Doadrio, Antonio L., Sánchez-Montero, Jose María · 2019 · Expert Opinion on Drug Discovery
13. Multi-target Design Strategies in the Context of Alzheimer’s Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces
    Michela Rosini, Elena Simoni, Anna Minarini, Carlo Melchiorre · 2014 · Neurochemical Research
14. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
    Tao Wang, Xiao-huan Liu, Jing Zhi Guan, Shun Ge, Mianbin Wu, Jianping Lin, Li-rong Yang · 2019 · European Journal of Medicinal Chemistry
15. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease
    Renshi Li, Xiaobing Wang, Xiao-Jun Hu, Ling‐Yi Kong · 2013 · Bioorganic & Medicinal Chemistry Letters
16. 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies
    Tarek Mohamed, Praveen P. N. Rao · 2016 · European Journal of Medicinal Chemistry
17. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease
    Zhipei Sang, Xiaoming Qiang, Yan Li, Wenmin Yuan, Qiang Liu, Yikun Shi, Wei Ang, Youfu Luo, Zhenghuai Tan, Yong Deng · 2015 · European Journal of Medicinal Chemistry
18. The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases
    Salvatore Bongarzone, María Laura Bolognesi · 2011 · Expert Opinion on Drug Discovery
19. One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug
    Rebecca E. Hughes, Katarina M. Nikolic, Rona Ruth Ramsay · 2016 · Frontiers in Neuroscience
20. Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
    Dubravka Švob Štrac, Nela Pivac, Ilse Julia Smolders, Wieslawa Agnieszka Fogel, Philippe De Deurwaerdère, Giuseppe Di Giovanni · 2016 · Frontiers in Neuroscience
21. LigBuilder V3: A Multi-Target de novo Drug Design Approach
    Yaxia Yuan, Jianfeng Pei, Luhua Lai · 2020 · Frontiers in Chemistry
22. Design, classification, and adverse effects of NSAIDs: A review on recent advancements
    Minhajul Arfeen, Ashish Srivastava, Noopur Srivastava, Riaz A. Khan, Suliman A. Almahmoud, Hamdoon Abdelhamid Mohammed · 2024 · Bioorganic & Medicinal Chemistry
23. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol
    Fei Mao, Jun Yan, Jianheng Li, Xian Jia, Hui Miao, Yang Sun, Ling Huang, Xingshu Li · 2014 · Organic & Biomolecular Chemistry
24. Novel 8‐Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer′s Disease
    Federica Prati, Christian Bergamini, Romana Fato, Ondřej Soukup, Jan Korábečný, Vincenza Andrisano, Manuela Bartolini, María Laura Bolognesi · 2016 · ChemMedChem
25. Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer’s disease
    Michela Rosini, Elena Simoni, Manuela Bartolini, Andrea Tarozzi, Riccardo Matera, Andrea Milelli, Patrizia Hrelia, Vincenza Andrisano, María Laura Bolognesi, Carlo Melchiorre · 2011 · European Journal of Medicinal Chemistry
26. New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease
    Beatriz López-Iglesias, Concepción Pérez, Jose Angel Morales-Garcia, Sandra Alonso‐Gil, Ana Pérez‐Castillo, Alejandro Romero, Manuela G. López, Mércedes Villarroya, Santiago Conde, Marı́a Isabel Rodrı́guez-Franco · 2014 · Journal of Medicinal Chemistry
27. Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
    Leonardo Pisani, Marco Catto, Francesco Leonetti, Orazio Nicolotti, Angela Stefanachi, Francesco Campagna, Angelo Carotti · 2011 · Current Medicinal Chemistry
28. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation
    Wenjun Shan, Ling Huang, Qi Zhou, Fan-Chao Meng, Xingshu Li · 2011 · European Journal of Medicinal Chemistry
29. Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents
    Cheng‐Shi Jiang, Yan Fu, Li Zhang, Jing‐Xu Gong, Zhenzhong Wang, Wei Xiao, Haiyan Zhang, Yue‐Wei Guo · 2014 · Bioorganic & Medicinal Chemistry Letters
30. Benzenediol-berberine hybrids: Multifunctional agents for Alzheimer’s disease
    Huailei Jiang, Xu Wang, Ling Huang, Zonghua Luo, Tao Su, Ke Ding, Xingshu Li · 2011 · Bioorganic & Medicinal Chemistry
31. Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease
    Sai‐Sai Xie, Jinshuai Lan, Xiaobing Wang, Zhimin Wang, Neng Jiang, Fan Li, Jia‐Jia Wu, Jin Qiang Wang, Ling‐Yi Kong · 2016 · Bioorganic & Medicinal Chemistry
32. Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer’s Disease Agents
    Serena Montanari, Laura Scalvini, Manuela Bartolini, Federica Belluti, Silvia Gobbi, Vincenza Andrisano, Alessia Ligresti, Vincenzo Di Marzo, Silvia Rivara, Marco Mor et al. · 2016 · Journal of Medicinal Chemistry
33. Novel Carbamates as Orally Active Acetylcholinesterase Inhibitors Found to Improve Scopolamine-Induced Cognition Impairment: Pharmacophore-Based Virtual Screening, Synthesis, and Pharmacology
    Shailendra S. Chaudhaery, Kuldeep Kumar Roy, Neeraj Shakya, Gunjan Saxena, Shreesh Raj Sammi, Aamir Nazir, Chandishwar Nath, Anil Kumar Saxena · 2010 · Journal of Medicinal Chemistry
34. Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and α-glycosidase enzymes
    Sadaf Hashmi, Samra Khan, Zahid Shafiq, Parham Taslımı, Muhamamd Ishaq, Nastaran Sadeghian, Halide Sedef Karaman, Naeem Akhtar, Muhammad Fakhrul Islam, Asnuzilawati Asari et al. · 2020 · Bioorganic Chemistry
35. Hybrids: a new paradigm to treat Alzheimer’s disease
    Manjinder Singh, Maninder Kaur, Navriti Chadha, Om Silakari · 2015 · Molecular Diversity
36. Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment
    Anna Minarini, Andrea Milelli, Vincenzo Tumiatti, Michela Rosini, E. Simoni, María Laura Bolognesi, Vincenza Andrisano, Manuela Bartolini, Elisa Motori, Cristina Angeloni et al. · 2011 · Neuropharmacology
37. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease
    Chao Zhang, Qiao-Yi Du, Lang-di Chen, Wenhao Wu, Siyan Liao, Lihong Yu, Xintong Liang · 2016 · European Journal of Medicinal Chemistry
38. Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates
    Luca Piemontese, Daniel Tomás, Asha Hiremathad, Vito Capriati, Emanuel Candeias, Sandra M. Cardoso, Sı́lvia Chaves, Maria Amélia Santos · 2018 · Journal of Enzyme Inhibition and Medicinal Chemistry
39. 7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies
    Jan Korábečný, Rafael Doležal, Pavla Cabelova, Anna Horova, Eva Hruba, Jan Říčný, Lukáš Sedláček, Eugenie Nepovimová, Katarína Špilovská, Martin Andrš et al. · 2014 · European Journal of Medicinal Chemistry
40. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease
    Asha Hiremathad, Rangappa Sangappa Keri, A. Raquel Esteves, Sandra M. Cardoso, Sı́lvia Chaves, Maria Amélia Santos · 2018 · European Journal of Medicinal Chemistry
41. Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease
    Hong Yao, Giuseppe Uras, Pengfei Zhang, Shengtao Xu, Ying Yin, Jie Liu, Shuai Qin, Xinuo Li, Stephanie Allen, Renren Bai et al. · 2021 · Journal of Medicinal Chemistry
42. Evaluation of the Antioxidant and Antiradical Properties of Some Phyto and Mammalian Lignans
    Leyla Polat Köse, İlhami Gülçın · 2021 · Molecules
43. Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor
    Angelo Danilo Favia, Damien Habrant, Rita Scarpelli, Marco Migliore, Clara Albani, Sine Mandrup Bertozzi, Mauro Dionisi, Glauco Tarozzo, Daniele Piomelli, Andrea Cavalli et al. · 2012 · Journal of Medicinal Chemistry
44. The emergence of designed multiple ligands for neurodegenerative disorders
    Werner J. Geldenhuys, Moussa B. H. Youdim, Richard T. Carroll, Cornelis J. Van der Schyf · 2011 · Progress in Neurobiology
45. Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents
    Xiaokang Li, Huan Wang, Zhengyu Lu, Xinyu Zheng, Wei Min NI, Jin Zhu, Yan Fu, Fulin Lian, Naixia Zhang, Jian Li et al. · 2016 · Journal of Medicinal Chemistry
46. Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
    Valeria Capurro, Perrine Busquet, João Pedro Lopes, Rosalia Bertorelli, Glauco Tarozzo, María Laura Bolognesi, Daniele Piomelli, Angelo M. Reggiani, Andrea Cavalli · 2013 · PLoS ONE
47. Thiazolidione derivatives as novel antibiofilm agents: Design, synthesis, biological evaluation, and structure–activity relationships
    Bin Pan, Renzheng Huang, Likang Zheng, Chen Chen, Shiqing Han, Di Qu, Mingli Zhu, Ping Wei · 2010 · European Journal of Medicinal Chemistry
48. Novel hybrid DHPM-fatty acids: Synthesis and activity against glioma cell growth in vitro
    Tamara G.M. Treptow, Fabrício Figueiró, Elisa Helena Farias Jandrey, Ana Maria Oliveira Battastini, Christianne Gazzana Salbego, Juliana Bender Hoppe, Priscila S. Taborda, Sabrina B. Rosa, Luciana A. Piovesan, Caroline Da Ros Montes D’Oca et al. · 2015 · European Journal of Medicinal Chemistry
49. Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: an in silico approach
    Pravin Sundarao Ambure, Jyotsna Bhat, Tomasz Puzyn, Kunal Roy · 2018 · Journal of Biomolecular Structure and Dynamics
50. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation
    Wen Luo, Yan‐Ping Li, Yan He, Shi‐Liang Huang, Jia‐Heng Tan, Tian‐Miao Ou, Ding Li, Lian‐Quan Gu, Zhi‐Shu Huang · 2010 · Bioorganic & Medicinal Chemistry
51. Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives
    Cristóbal de los Rı́os, Javier Egea, Jose Luis Marco, Rafael M. Leon, Abdelouahid Samadi, Isabel Iriepa, Ignacio Moraleda, E. Galvez‐Ruano, Antonio G. Garcı́a, Manuela G. López et al. · 2010 · Journal of Medicinal Chemistry
52. Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease
    Yixiang Xu, Huan Wang, Xiaokang Li, Shengnan Dong, Wenwen Liu, Qi Gong, Tianduanyi Wang, Yun Tang, Jin Zhu, Jian Li et al. · 2017 · European Journal of Medicinal Chemistry
53. Multitarget Strategies in Alzheimer’S Disease: Benefits and Challenges on the Road to Therapeutics
    Michela Rosini, Elena Simoni, Roberta Caporaso, Anna Minarini · 2016 · Future Medicinal Chemistry
54. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
    P R Bharadwaj, Kristyn Alissa Bates, Tenielle Porter, Elham Teimouri, George L. Perry, John Steele, Sam Gandy, David Groth, Ralph Nigel Martins, Giuseppe Verdile · 2013 · Translational Psychiatry
55. Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases
    Federica Prati, Elisa Uliassi, María Laura Bolognesi · 2014 · MedChemComm
56. Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease
    Jinshuai Lan, Yue Ding, Yun Liu, Ping Kang, Jianwei Hou, Xinyu Zhang, Sai‐Sai Xie, Tong Zhang · 2017 · European Journal of Medicinal Chemistry
57. Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease
    Yan Li, Xiaoming Qiang, Li Luo, Yang Xia, Ganyuan Xiao, Qi Liu, Jiachen Ai, Zhenghuai Tan, Yong Deng · 2016 · European Journal of Medicinal Chemistry
58. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal structure and in-vitro biological evaluation
    Shoaib Manzoor, Santosh Kumar Prajapati, Shreyasi Majumdar, Md Kausar Raza, Moustafa Tarek Gabr, Shivani Kumar, Kavita Pal, Haroon Ur Rashid, Suresh Kumar, Sairam Krishnamurthy et al. · 2021 · European Journal of Medicinal Chemistry
59. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
    Wenyu Wu, Yu-Chen Dai, Nian‐Guang Li, Ze‐Xi Dong, Ting Gu, Zhi‐Hao Shi, Xin Xue, Yuping Tang, Jin‐Ao Duan · 2017 · Journal of Enzyme Inhibition and Medicinal Chemistry
60. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents
    Jesús M. Roldán-Peña, Daniel Alejandre-Ramos, Óscar López, Inés Maya, Irene Lagunes, José M. Padrón, Emiliano Peña‐Altamira, Manuela Bartolini, Barbara Monti, María Laura Bolognesi et al. · 2017 · European Journal of Medicinal Chemistry
61. Novel Tacrine‐Grafted Ugi Adducts as Multipotent Anti‐Alzheimer Drugs: A Synthetic Renewal in Tacrine–Ferulic Acid Hybrids
    Mohamed Benchekroun, Manuela Bartolini, Javier Egea, Alejandro Romero, Elena Soriano, Marc Pudlo, Vincent Luzet, Vincenza Andrisano, M. Luísa Jimeno, Manuela G. López et al. · 2014 · ChemMedChem
62. Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates
    Elisabet Viayna, Raimon Sabaté, Diego Muñoz‐Torrero · 2013 · Current Topics in Medicinal Chemistry
63. NO and HNO donors, nitrones, and nitroxides: Past, present, and future
    Catarina Oliveira, Sofia Benfeito, Carlos Fernandes, Fernando Cagide, Tiago Silva, Fernanda Borges · 2017 · Medicinal Research Reviews
64. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease
    Francesco Mesiti, Daniel Chavarria, Alexandra Gaspar, Stefano Alcaro, Fernanda Borges · 2019 · European Journal of Medicinal Chemistry
65. Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties
    Sai‐Sai Xie, Jinshuai Lan, Xiaobing Wang, Neng Jiang, Ge Dong, Zhongrui Li, Kelvin D.G. Wang, Ping-Ping Guo, Ling‐Yi Kong · 2015 · European Journal of Medicinal Chemistry
66. Systems Biology Brings New Dimensions for Structure-Based Drug Design
    Jianfeng Pei, Ning Yin, Xiaomin Ma, Luhua Lai · 2014 · Journal of the American Chemical Society
67. Tau-Derived-Hexapeptide 306 VQIVYK 311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design
    Tarek Mohamed, Tuan Anh Hoang, Masoud Jelokhani‐Niaraki, Praveen P. N. Rao · 2013 · ACS Chemical Neuroscience
68. Quinolone–benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease
    Marc Pudlo, Vincent Luzet, Lhassane Ismaïli, Isabelle Tomassoli, Anne Iutzeler, Bernard Refouvelet · 2014 · Bioorganic & Medicinal Chemistry
69. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer’s disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation
    Галина Ф. Махаева, Надежда Владимировна Ковалева, Natalia P. Boltneva, Sofya V. Lushchekina, Елена Владимировна Рудакова, Tatyana S. Stupina, Alexey A. Terentiev, Igor V. Serkov, Alexey N. Proshin, Eugene V. Radchenko et al. · 2019 · Bioorganic Chemistry
70. Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies
    Bhawna, Ashwani Kumar, Meenakshi Bhatia, Archana Kapoor, Prof Parvin Kumar, Sunil Kumar · 2022 · European Journal of Medicinal Chemistry
71. 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies
    Katarína Špilovská, Jan Korábečný, Jan Král, Anna Horova, Kamil Musílek, Ondřej Soukup, Lucie Drtinová, Zuzana Gažová, Katarína Šipošová, Kamil Kuča · 2013 · Molecules
72. Profiling donepezil template into multipotent hybrids with antioxidant properties
    Eva Mezeiová, Katarína Špilovská, Eugenie Nepovimová, Lukáš Górecki, Ondřej Soukup, Rafael Doležal, David Maliňák, Jana Janočková, Daniel Jun, Kamil Kuča et al. · 2018 · Journal of Enzyme Inhibition and Medicinal Chemistry
73. Toward a Rational Design of Multitarget-Directed Antioxidants: Merging Memoquin and Lipoic Acid Molecular Frameworks
    María Laura Bolognesi, Andrea Cavalli, Christian Bergamini, Romana Fato, Giorgio Lenaz, Michela Rosini, Manuela Bartolini, Vincenza Andrisano, Carlo Melchiorre · 2009 · Journal of Medicinal Chemistry
74. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
    Abdelouahid Samadi, Cristóbal de los Rı́os, Irene Bolea, Mourad Chioua, Isabel Iriepa, Ignacio Moraleda, Manuela Bartolini, Vincenza Andrisano, E. Galvez‐Ruano, Carolina Valderas et al. · 2012 · European Journal of Medicinal Chemistry
75. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer’s disease
    Bruno Tasso, Marco Catto, Orazio Nicolotti, Federica Novelli, Michele Tonelli, Ilenia Giangreco, Leonardo Pisani, Anna Sparatore, Vito Boido, Angelo Carotti et al. · 2011 · European Journal of Medicinal Chemistry
76. Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism
    Jana Hroudová, Namrata Singh, Zdeněk Fišar, Kallol Kumar Ghosh · 2016 · European Journal of Medicinal Chemistry
77. Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease
    Xiaohui Wang, Xiaoyong Wang, Zijian Guo · 2018 · Coordination Chemistry Reviews
78. Polypharmacology: promises and new drugs in 2022
    Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker · 2023 · Pharmacological Reports
79. 2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents
    Stefano Rizzo, Andrea Tarozzi, Manuela Bartolini, Grégory Da Costa, Alessandra Bisi, Silvia Gobbi, Federica Belluti, Alessia Ligresti, Marco Allarà, Jean‐Pierre Monti et al. · 2012 · European Journal of Medicinal Chemistry
80. Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease
    Abdelouahid Samadi, Mourad Chioua, Irene Bolea, Cristóbal de los Rı́os, Isabel Iriepa, Ignacio Moraleda, Ágatha Bastida, Gerard Esteban, Mercedes Unzeta, E. Galvez‐Ruano et al. · 2011 · European Journal of Medicinal Chemistry
81. The pharmacology of tacrine at N -methyl- d -aspartate receptors
    Martin Hořák, Kristína Holubová, Eugenie Nepovimová, Jan Krůšek, Martina Kaniaková, Jan Korábečný, Ladislav Vyklický, Kamil Kuča, Aleš Stuchlı́k, Jan Říčný et al. · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
82. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties
    Natalia Szałaj, Marek Bajda, Mirosław Skrok, Katarzyna Kurpiewska, Krzysztof Lewiński, Boris Brus, Anja Hafner Pišlar, Janko Kos, Stanislav Gobec, Barbara Malawska · 2015 · European Journal of Medicinal Chemistry
83. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease
    Emna Maalej, Fakher Chabchoub, María Jesús Oset‐Gasque, Mario Esquivias-Pérez, María Pilar González, Leticia Monjas, Concepción Pérez, Cristóbal de los Rı́os, Marı́a Isabel Rodrı́guez-Franco, Isabel Iriepa et al. · 2012 · European Journal of Medicinal Chemistry
84. Selective Dual Inhibitors of CYP19 and CYP11B2: Targeting Cardiovascular Diseases Hiding in the Shadow of Breast Cancer
    Qingzhong Hu, Lina Yin, Rolf W. Hartmann · 2012 · Journal of Medicinal Chemistry
85. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1 H )-one derivatives as inhibitors of cholinesterases
    Muhammad Sarfraz, Nargis Sultana, Umer Rashid, Muhammad Safwan Akram, Abdul Sadiq, Muhammad Ilyas Tariq · 2017 · Bioorganic Chemistry
86. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer’s disease
    Giang Le-Nhat-Thuy, Nga Nguyễn Thị, Hai Pham‐The, Tuyet Anh Dang Thi, Huong Nguyen Thi, Thu Ha Nguyen Thi, Sa Nguyễn Hoàng, Tuyen Van Nguyen · 2020 · Bioorganic & Medicinal Chemistry Letters
87. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update
    Swapnil K. Sharma, Neha Chauhan, Swati Paliwal, Smita Jain, Kanika Verma, Sarvesh Paliwal · 2022 · Mini-Reviews in Medicinal Chemistry
88. 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease
    Federica Prati, Angela De Simone, Andrea Armirotti, Maria Summa, Daniela Pizzirani, Rita Scarpelli, Sine Mandrup Bertozzi, Daniel I. Pérez, Vincenza Andrisano, Ana Pérez‐Castillo et al. · 2015 · ACS Chemical Neuroscience
89. De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy
    Erchang Shang, Yaxia Yuan, Xinyi Chen, Ying Liu, Jianfeng Pei, Luhua Lai · 2014 · Journal of Chemical Information and Modeling
90. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer’s disease
    Xuelian Yang, Pei Cai, Qiaohong Liu, Jia‐Jia Wu, Yong Yin, Xiaobing Wang, Ling‐Yi Kong · 2018 · Bioorganic & Medicinal Chemistry
91. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice
    Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, Richard L. Jayaraj, David Reiner‐Link, Shreesh Kumar Ojha, Rami Beiram, Holger Stark, Dorota Łażewska, Katarzyna Kieć‐Kononowicz et al. · 2019 · Chemico-Biological Interactions
92. Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents
    Lei Fang, Xubin Fang, Shaohua Gou, Amelie Lupp, Isabell Lenhardt, Haopeng Sun, Zhangjian Huang, Yao Chen, Yihua Zhang, Christian Fleck · 2014 · European Journal of Medicinal Chemistry
93. Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity
    María Laura Bolognesi, Manuela Bartolini, Andrea Tarozzi, Fabiana Morroni, Federica Lizzi, Andrea Milelli, Anna Minarini, Michela Rosini, Patrizia Hrelia, Vincenza Andrisano et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
94. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies
    Ornella Di Pietro, Francisco Javier Pérez-Areales, Jordi Juárez‐Jiménez, Alba Espargaró, M. Victòria Clos, Belén Pérez, Rodolfo Lavilla, Raimon Sabaté, Francisco Javier Luque, Diego Muñoz‐Torrero · 2014 · European Journal of Medicinal Chemistry
95. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease
    Yan He, Pei-Fen Yao, Shuo-bin Chen, Zhihong Huang, Shi‐Liang Huang, Jia‐Heng Tan, Ding Li, Lian‐Quan Gu, Zhi‐Shu Huang · 2013 · European Journal of Medicinal Chemistry
96. Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease
    Corey R. Hopkins, Craig W. Lindsley, Colleen Marie Niswender · 2009 · Future Medicinal Chemistry
97. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor
    Óscar M. Bautista‐Aguilera, Abdelouahid Samadi, Mourad Chioua, Katarina M. Nikolic, Slavica Filipić, Danica Agbaba, Elena Soriano, Lucía de Andrés, Marı́a Isabel Rodrı́guez-Franco, Stefano Alcaro et al. · 2014 · Journal of Medicinal Chemistry
98. Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment
    Сергей Олегович Бачурин, E. F. Shevtsova, Галина Ф. Махаева, Vladimir V. Grigoriev, Natalia P. Boltneva, Надежда Владимировна Ковалева, Sofya V. Lushchekina, Pavel N. Shevtsov, Неганова Маргарита Евгеньевна, Olga M. Redkozubova et al. · 2017 · Scientific Reports
99. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease
    Ping Bai, Keren Wang, Pengfei Zhang, Jian Shi, Xinfeng Cheng, Qi Zhang, Cheng Zheng, Yao Cheng, Jian Yang, Xiaoxia Lü et al. · 2019 · European Journal of Medicinal Chemistry
100. Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies
     Irene Sola, Ester Aso, Daniela Frattini, Irene López‐González, Alba Espargaró, Raimon Sabaté, Ornella Di Pietro, Francisco Javier Luque, M. Victòria Clos, Isidró Ferrer et al. · 2015 · Journal of Medicinal Chemistry